1. Home ›
  2. upcoming IPO ›
  3. Infinion Biopharma IPO

Infinion Biopharma IPO

Infinion Biopharma is a research-driven life sciences company that combines biophysics and engineering with traditional pharmacology and biochemistry to produce high-value, innovative products across a range of therapeutic areas. The company’s mission is to be a global leader in biopharmaceuticals, improving the lives of patients across the world.
The initial public offering (IPO) comprises the sale of 45 lakh equity shares at a face value of Rs. 10 per share. The company may consider a pre-IPO placement of up to 7 lakh equity shares.

The company intends to utilize the net proceeds for the following objects -
a) Investment in Mobius Biomedical Inc.
b) Acquisition of License for Product Development of Skin Care and Women‘s Health Product;
c) Working Capital Requirements;
d) Sales, Marketing and Distribution Expenses for setting up our geographical reach
e) General Corporate Purposes

Opening Date

To be announced

Closing Date

To be announced

Price Band

To be announced

Issue Size

To be announced

Face Value

To be announced

Market Lot

To be announced

Listing at NSE, BSE

IPO Open Date To be announced
IPO Close Date To be announced
Allotment Date To be announced
Initiation Of Refunds To be announced
Credit Of Shares To
Demat Account		 To be announced
IPO Listing Date To be announced
UPI Mandate Expiry Date To be announced

Financial Highlights

Particulars For the year/period ended (₹ in million)
  FY21 FY20 FY19
Total Income 68,987.06 NA NA
EBITDA NA NA NA
EBITDA Margin (%) NA NA NA
Profit After Tax 64,240.27 (13,697.46) (3,635.15)
EPS 6.24 (1.71) (0.66)
ROE NA NA NA

How to apply in IPO via UPI on Dynami

A simple and smartest way to Apply in IPO online via Religare Dynami Mobile App

Why should you invest in the Infinion Biopharma IPO?

Here are our top reasons:

  • They have developed significant business relationships with several USA and UK pharmaceutical companies for research, design, and development of a vast range of therapeutic products.
  • The company developed a robust country-wide network to distribute its products to the Indian markets.
  • Infinion strongly invests in research and development that helps it to receive first mover advantage in creating new drugs.
  • hey are expanding and in 2020, they obtained a 10.43 percent stake in UK-based research oriented company, Aurum Bioscience Ltd. (ABL).

How to apply for Infinion Biopharma Ltd. IPO?

Retail investors need to apply for the IPO using UPI

UPI

  • Link your bank account to a UPI ID.
  • Register your UPI id with your Demat account.
  • Subscribe for Infinion Biopharma Ltd. IPO and approve the payment on your UPI ID.

Demat Account

  • If you are an existing Dynami user, Pre-Apply Now!
  • For new investor, get free demat account opening offer on our web & Dynami App ensuring a smooth and hassle-free experience for your initial investments.

Know before investing

Strengths Risks
Experienced Promoters with Extensive Domain Knowledge If the products that the company commercialises do not perform as expected, the business may be adversely affected
Global Patented Licensed Technology Significantly dependent upon third party contract manufacturers for the product development as well as further manufacture of our licensed products
First mover advantage Inability to generate sufficient cash flows might adversely affect the business

How to open a Demat & Trading Account?

Demat & Trading Account
Form fill up Demat & Trading Account

Fill up your personal details in the form above

Share Personal Details Demat & Trading Account

Fill up your DOB, PAN, email & bank account details

OTP Authentication Demat & Trading Account

Upload your photo and e-sign your application via Aadhaar OTP

How to open a Demat & Trading Account?

Open Demat Account

Frequently asked questions

  • An IPO also known as initial pulic offering or stock launch is a process when a private company sale its shares to public for the first time. Learn more about IPO at our knowledge centre.

  • Infinion Biopharma will sell around 45 lakh equity shares of face value of Rs 10 per share through a public route for an undisclosed amount.

  • A lot size is the minimum number of shares that an investor has to bid for. A lot size differs for each IPO and is fixed by the company.

  • IPO Price Band is the price range within which investors can bid for the shares. The minimum price is called the floor price and the maximum price is called the cap price.

  • Issue size is the total value of an IPO. It is calculated by multiplying the number of shares offered by the company by the issue price per share.

  • You will receive an email on your registered email id if the IPO shares are allotted to you. Alternatively, you can also visit the registrar of the company’s official website and provide the details as asked in the allotment status section of the website.

  • IPOs, as such, do not have any taxes. You are taxed only when you decide to sell the IPO shares. Any monetary profit you make while selling the IPO shares is referred to as ‘capital gains’.

    Capital gains tax is charged depending on how long you held the shares for. If you owned the shares for less than 12 months, it is considered as short-term capital gains and if it is over 12 months, it is referred as long-term capital gains.

    Tax on short-term capital gains is 15%. It is 10% for equity gains in the long run (over 12 months). Do remember that you are taxed if the equity proceeds exceed Rs 1 lakh.